Rujia Mi

497 total citations
14 papers, 268 citations indexed

About

Rujia Mi is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Rujia Mi has authored 14 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Rujia Mi's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Rujia Mi is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Rujia Mi collaborates with scholars based in China. Rujia Mi's co-authors include Huiyong Shen, Mengjun Ma, Yuhang Jiang, Zhaopeng Cai, Xi Shen, Wenzhao Liu, Ming Ma, Yueguo Wu, Yimin Jiang and Hongyu Li and has published in prestigious journals such as Oncogene, Cellular and Molecular Life Sciences and Stem Cells.

In The Last Decade

Rujia Mi

13 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rujia Mi China 9 183 65 41 33 29 14 268
Yanfeng Wu China 8 211 1.2× 85 1.3× 64 1.6× 18 0.5× 39 1.3× 16 304
Emre Can Tüysüz Türkiye 11 138 0.8× 97 1.5× 39 1.0× 32 1.0× 41 1.4× 19 302
Tania Tsatralis Australia 10 191 1.0× 79 1.2× 40 1.0× 15 0.5× 34 1.2× 11 335
Yonggang Wu China 11 206 1.1× 100 1.5× 63 1.5× 19 0.6× 27 0.9× 24 338
Benshuai You China 10 257 1.4× 177 2.7× 32 0.8× 28 0.8× 34 1.2× 16 353
Zijun Huo China 11 177 1.0× 65 1.0× 52 1.3× 33 1.0× 68 2.3× 26 350
Xinnv Xu China 11 195 1.1× 116 1.8× 45 1.1× 68 2.1× 17 0.6× 16 325
Renjie Chai China 8 283 1.5× 115 1.8× 40 1.0× 41 1.2× 20 0.7× 11 372
Jiawei Yu China 11 232 1.3× 151 2.3× 62 1.5× 15 0.5× 35 1.2× 25 337

Countries citing papers authored by Rujia Mi

Since Specialization
Citations

This map shows the geographic impact of Rujia Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rujia Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rujia Mi more than expected).

Fields of papers citing papers by Rujia Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rujia Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rujia Mi. The network helps show where Rujia Mi may publish in the future.

Co-authorship network of co-authors of Rujia Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Rujia Mi. A scholar is included among the top collaborators of Rujia Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rujia Mi. Rujia Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Shen, Xin, Mengjun Ma, Rujia Mi, et al.. (2024). EFHD1 promotes osteosarcoma proliferation and drug resistance by inhibiting the opening of the mitochondrial membrane permeability transition pore (mPTP) by binding to ANT3. Cellular and Molecular Life Sciences. 81(1). 236–236. 3 indexed citations
3.
Feng, Pei, Zhongyu Xie, Tingting Chen, et al.. (2023). Enhancer-mediated FOXO3 expression promotes MSC adipogenic differentiation by activating autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166975–166975. 4 indexed citations
4.
Wang, Peng, et al.. (2023). SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake. Cancer Letters. 576. 216412–216412. 21 indexed citations
5.
Yu, Wenhui, Zhongyu Xie, Jiajie Lin, et al.. (2023). Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis. Bone Research. 11(1). 30–30. 12 indexed citations
6.
Ma, Mengjun, Hongyu Li, Rujia Mi, et al.. (2023). Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop. Oncogene. 43(1). 47–60. 9 indexed citations
7.
Zhang, Yunhui, Wenjie Liu, Zhaopeng Cai, et al.. (2022). Impairment of APPL1/Myoferlin facilitates adipogenic differentiation of mesenchymal stem cells by blocking autophagy flux in osteoporosis. Cellular and Molecular Life Sciences. 79(9). 488–488. 6 indexed citations
8.
Wang, Shan, Rujia Mi, Zhaopeng Cai, et al.. (2022). DAPK1 Interacts with the p38 Isoform MAPK14, Preventing Its Nuclear Translocation and Stimulation of Bone Marrow Adipogenesis. Stem Cells. 40(5). 508–522. 6 indexed citations
9.
Wu, Yueguo, Rujia Mi, Wenzhao Liu, et al.. (2021). ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Molecular Therapy — Nucleic Acids. 26. 135–147. 69 indexed citations
10.
Li, Hongyu, Xin Shen, Mengjun Ma, et al.. (2021). ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 340–340. 60 indexed citations
11.
Ma, Mengjun, Hongyu Li, Peng Wang, et al.. (2021). ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes. iScience. 24(7). 102791–102791. 22 indexed citations
12.
Wang, Shan, Hongjun Su, Fenglei Chen, et al.. (2021). Effects of long-term culture on the biological characteristics and RNA profiles of human bone-marrow-derived mesenchymal stem cells. Molecular Therapy — Nucleic Acids. 26. 557–574. 32 indexed citations
13.
Ma, Mengjun, Zhaopeng Cai, Peng Wang, et al.. (2021). SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis. Stem Cells. 39(5). 581–599. 15 indexed citations
14.
Li, Ming, Zhongyu Xie, Zhaopeng Cai, et al.. (2019). lncRNA-mRNA expression profiles and functional networks of mesenchymal stromal cells involved in monocyte regulation. Stem Cell Research & Therapy. 10(1). 207–207. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026